| 14.00-14.30 | Coffee, welcome to the meeting, opening words by president S. Ylä-Herttuala |
| 14.30-15.30 | Andy Baker (Univ. of Glasgow): "Analysis of Transgenes and Modified Vectors for Vascular Gene Therapy" |
| 15.30-16.00 | Akseli Hemminki (Univ. Alabama at Birmingham): "Towards molecular based therapies for cancer: gene therapy as a paradigm" |
| 16.00-16.15 | Risto Ala-Aho (Turku Centre for Biotechnology): "Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells" |
| 16.15-16.30 | Suvi-Katri Leivonen (Turku Centre for Biotechnology): "Recombinant Smad adenoviruses as tools in studying the regulation of collagenase-3 (MMP-13) expression" |
| 16.30-17.00 | Break |
| 17.00-17.15 | Minna Laine (Univ. of Helsinki): "Adenovirus-mediated gene therapy using non-viral promoters in the AGU mouse model" |
| 17.15-17.30 | Jonna Koponen (AIVI, Kuopio): "Doxycycline regulated lentiviral vector system" |
| 17.30-17.45 | Tuomas Rissanen (AIVI, Kuopio): "Intramuscular and intra-arterial adenoviral gene transfer of VEGF and FGF-4 for Therapeutic Angiogenesis in a Modified Rabbit Hindlimb Ischemia Model" |
| 17.45-18.00 | Johanna Markkanen (AIVI, Kuopio): "Effects of different VEGFs and angiopoietin-1 on vascular permeability and angiogenesis in rabbit skeletal muscle"
|
| 18.00-18.15 | Tatu Tarkka (Univ. of Oulu): "VEGF gene transfer stimulates bone defect healing in rat femur"
|
| 18.15-18.30 | Hanna Puhakka (AIVI, Kuopio): "MMP-targeted adenovirus encoding tissue inhibitor of metalloproteinase-1 (TIMP-1) with altered virus tropism reduces restenosis after intravascular gene transfer" |
| 18.30- | FGTS business meeting, Dinner |
